Jean-Jacques Mourad: Congratulations to the French Authors for Clarifying Aspirin Use in Horton’s Disease
Jean-Jacques Mourad, Head of Internal Medicine at Franco-British Hospital, shared a post on LinkedIn about a recent article by Maxime Beydon, published in JAMA Network Open, adding:
“When well-constructed and properly analyzed cohort studies provide answers to the gray areas left by randomized trials…
All my sincere congratulations to the French authors of this work, which allows us to weigh a little more clearly the pros and cons of aspirin in patients treated for a Horton’s.”
Title: Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis
Authors: Maxime Beydon, David Hajage, Alexis F. Guédon, Fabrice Carrat, Raphaèle Seror, Florence Tubach
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 19, 2026, 14:36Francisco Ujueta: Pulmonary Embolism Care Doesn’t End at the Acute Phase
-
Apr 19, 2026, 14:35Flora Peyvandi: Marking the Beginning of a Future with Less Suffering on World Haemophilia Day
-
Apr 19, 2026, 14:34Chokri Ben Lamine: 50 High-Yield Pearls on Hemoglobin Cutoffs for Anaemia from WHO 2024 Guideline
-
Apr 19, 2026, 14:31Kate Iyore: Simple Explanation of Deep Vein Thrombosis and Pulmonary Embolism
-
Apr 19, 2026, 14:08Emily Smith: From Personal Experience to Global Advocacy on World Haemophilia Day
-
Apr 19, 2026, 13:52David Montani: SOX17 Variants and Their Broader Impact in Pulmonary Arterial Hypertension
-
Apr 19, 2026, 13:42Wolfgang Miesbach: Key Insights on Hemophilia Care at WFH 2026 Pre-Congress Workshop
-
Apr 19, 2026, 13:41Mary Cushman: Unprovoked VTE as a Marker of Increased Cardiovascular Mortality Risk
-
Apr 19, 2026, 13:31Danielle Plummer: Pulmonary Embolism in Pregnancy Requires Greater Awareness and Structured Evaluation